The effects of a-D-mannopyranosylmethyl-p-nitrophenyltriazene (MMNT) on mannosidases involved in asparagine-linked oligosaccharide processing were investigated. MMNT was found to inhibit the activity of rat liver Golgi a-mannosidase I in a concentration-dependent manner (50 inhibition with 0.18 mM-MMNT), whereas rat liver endoplasmic-reticulum a-mannosidase appeared to be resistant (less than 5 inhibition at 1 mM-MMNT). Jack-bean a-mannosidase was also sensitive to inhibition by MMNT (50 inhibition with 0.32 mM-MMNT). Treatment of influenza-virus-infected chick-embryo cells with 1 mM-MMNT led to a decrease in the formation of complex-type asparagine-linked oligosaccharides and an accumulation of high-mannose-type oligosaccharides with the composition Man8(GlcNAc)2 and Man7(GlcNAc)2 on the viral glycoproteins. The biological activities of influenza-virus haemagglutinin and neuraminidase synthesized in the presence of 1 mM-MMNT remained unchanged, but the virus was less infectious than the control.
INTRODUCTION
The complex-type and high-mannose-type oligosaccharide side chains present in mature N-glycosylated glycoproteins are derived from a common precursor Glc3Man9(GlcNAc)2 (Robbins et al., 1977) , which is assembled on a dolichol diphosphate carrier before being transferred en bloc to protein in the endoplasmic reticulum (ER) (Kornfeld & Kornfeld, 1985) . The sequence of reactions involved in the subsequent trimming of the precursor oligosaccharide are well documented (Kornfeld & Kornfeld, 1985) . The glucose residues are removed by glucosidases I and II (Grinna & Robbins, 1979; Burns & Touster, 1982) in the ER, and an ER a-mannosidase probably removes one mannose residue (Bischoff & Kornfeld, 1983) before the glycoprotein is transported to the cis-Golgi compartment, where the action of a-mannosidases IA/IB produces the high-mannose-type oligosaccharides containing five to eight mannose residues (Tabas & Kornfeld, 1979) . The Man5(GlcNAc)2 intermediate is the substrate for Nacetylglucosaminyltransferase I (Harpaz & Schachter, 1980) , which is located in the medial compartment of the Golgi apparatus and adds one N-acetylglucosamine residue. Mannosidase II now removes two further mannose residues (Tulsiani et al., 1982a) , and a second N-acetylglucosamine residue is subsequently added by N-acetylglucosaminyltransferase II. Further elongation of the oligosaccharide to produce complex-type glycans takes place in the trans-Golgi compartment (Kornfeld & Kornfeld, 1985) .
Specific inhibitors of the trimming glycosidases have proved to be useful in studying the biological roles of the oligosaccharide side chains of glycoproteins as well as the functional significance of the trimming pathway Datema et al., 1987) . Glucosidase inhibitors such as 1-deoxynojirimycin (Saunier et al., 1982) , N-methyl-l-deoxynojirimycin (Romero et al., 1983) and castanospermine (Pan et al., 1983) block the removal of the first glucose residue, whereas bromoconduritol (Datema et al., 1982) blocks the removal of the innermost glucose residue. Swainsonine is a potent inhibitor of Golgi ac-mannosidase II (Tulsiani et al., 1982b) , and the mannose analogue 1-deoxymannojinrmycin inhibits Golgi a.-mannosidase I (Fuhrmann et al., 1984; Bischoff & Kornfeld, 1984) . 1,4-Dideoxy-1,4-imino-D-mannitol appears to inhibit both trimming enzymes (Palamarczyk et al., 1985) .
Active-site-directed suicide substrates provide a novel means of irreversibly inhibiting enzyme activity, and glycosylmethyl-p-nitrophenyltriazenes are potential suicide substrates for glycosidases (Sinnott & Smith, 1978; Van Diggelen et al., 1980) . Thus it has been shown (Sinnott & Smith, 1978) that ,l-galactopyranosylmethylp-nitrophenyltriazene is a suicide substrate for the Escherichia coli lac Z ,3-galactosidase. Furthermore it was also shown (Van Diggelen et al., 1980) glucopyranosylmethyl-p-nitrophenyltriazene could specifically inactivate lysosomal fl-galactosidase and ,Jglucosidase respectively in cultured human fibroblasts.
On the basis of these findings the mannose derivative a-D-mannopyranosylmethyl-p-nitrophenyltriazene (MMNT) was synthesized and tested as an inhibitor of amannosidase activities present in rat liver Golgi and ER membranes and jack bean. Then the effect of MMNT on mannosidase trimming of influenza-virus glycoproteins was investigated. It is shown that MMNT inhibits Golgi a-mannosidase I and jack-bean a-mannosidase in vitro and oligosaccharide trimming in influenza-virus-infected chick-embryo cells, but has little effect on the ER amannosidase.
EXPERIMENTAL Materials a-D-Mannopyranosylmethylamine was prepared by a modification of the procedure of Coxon & Fletcher (1964) from a-D-mannopyranosyl cyanide, which was prepared by the method of Myers & Lee (1984) . pNitrobenzenediazonium tetrafluoroborate was obtained from Kodak (Rochester, NY, U.S.A.). Jack-bean amannosidase was from Sigma (Munich, Germany), and p-nitrophenyl a-D-mannopyranoside (pNPMan) and Pronase were from Serva (Heidelberg, Germany). BioRad (Munich, Germany) supplied Bio-Gel P4 and BioGel P6 as well as Bio-Beads SM-2. Endoglucosaminidase H was bought from Genzyme (Boston, MA, U.S.A. (Datema & Schwarz, 1981 (Docherty et al., 1986 ) procedure of Sinnott & Smith (1978) , as follows. a-D-Mannopyranosylmethylamine (11.75 mg) and NaHCO3 (10.25 mg) were dissolved in ice-cold water (1 ml) with stirring. p-Nitrobenzenediazonium tetrafluoroborate (13.5 mg) was then added and stirring was continued for 30 min on ice. The mixture was then diluted with ice-cold water (2 ml) and centrifuged at 4000 g to pellet the solids present. The pellet was washed once with 0.2 ml of water, and the combined supernatant fluids were extracted with ice-cold water-saturated diethyl ether to remove diazonium hydroxide. Triazene was removed from the ether-washed aqueous phase by extraction into butan-1-ol (4 x 1 ml). The combined butan-l-ol extracts were evaporated to dryness under oil-pump vacuum, and the residue was dissolved in ice-cold water (0.5 ml). The MMNT concentration was determined from its absorbance in ethanol at 362 nm (Sinnott & Smith, 1978) ; typically solutions of 15-25 mm concentration were obtained. Triazene was usually freshly prepared for each experiment. It could be stored overnight at 4°C, or for longer periods at -20°C (after immediate freezing in solid C02), without diminishing the effect. Preparation of rat liver Golgi membranes and assay of mannosidase I activity Rat liver Golgi membranes were prepared by the procedure of Tabas & Kornfeld (1982) with some modifications. All sucrose solutions were in 100 mMpotassium phosphate buffer, pH 6.5, containing 5 mMMgCl2. All solutions were ice-cold, and centrifugation steps were carried out at 4 'C. The freshly excised rat livers, placed in 4 vol. of buffered 0.5 M-sucrose, were cut up with scissors and scalpel and homogenized in an Ultra-Turrax tissue disintegrator (Janke und Kunkel AG, Staufen i. Br., Germany) until a uniform homogenate was obtained. The homogenate was centrifuged at 600 g for 10 min, and the supernatant fluid was layered on top of 1.3 M-sucrose (13 ml) in Beckman SW 28 centrifuge tubes. After centrifugation at 64000 gaV for 2 h in a Beckman SW 28 rotor, the membranes banding between the 0.5 M-and 1.3 M-sucrose layers were removed and adjusted to 1.1 M-sucrose with 1.3 M-sucrose. The crude membranes (18 ml portions) were then layered on top of 1.25 M-sucrose (8 ml) in Beckman SW 28 centrifuge tubes. Next 1 M-sucrose (7 ml) was layered on top of the membranes, and then 0.5 M-sucrose (5 ml) was layered on top of the 1 Msucrose. The discontinuous gradient was centrifuged at 83000 av for 90 min in a Beckman SW 28 rotor. The Golgi membranes, which band at the interface between the 0.5 M-and 1 M-sucrose layers, were removed, diluted to 0.25 M-sucrose and 0.4 M-NaCl, and centrifuged at 178000 gaV in a Beckman Ti6O rotor for 30 min. The pelleted membranes were taken up in 50 mM-Tris/HCl buffer, pH 7.5, containing 1 % Triton X-100 and 5 mMMgCl2 (1 ml per eight rat livers) and stored at -70 'C.
The rat liver Golgi membranes were used as a source of a-mannosidase I, which was assayed as follows.
Golgi membranes (10 l1) were incubated with [3H]-Man9GlcNAc (5000 d.p.m.), 25 mM-potassium phosphate buffer, pH 6.8, 0.05 % Triton X-100 and 2.5 mMMgCl2 in a total volume of 30 je1 for 1 h at 37 'C. The reaction was stopped by adding pyridine (20 t1l), and released mannose was separated from oligosaccharide by paper chromatography on Whatman 3MM paper with butan-1-ol/pyridine/water (6:4:3, by vol.) as the irri- 
Preparation and assay of ER o-mannosidase
ER membranes free of Golgi membranes were prepared exactly as described by Kreibach et al. (1978) as modified by Bischoff & Kornfeld (1983) with Aprotinin (0.17 trypsin-inhibitor unit/ml) in the sucrose and buffer solutions. The ER a-mannosidase was solubilized with sodium deoxycholate and partially purified by affinity chromatography through concanavalin ASepharose 4B as described by Bischoff & Kornfeld (1983) . The enzyme preparation was active in the presence of swainsonine (pNPMan substrate) or 1-deoxymannojirimycin (Man9GlcNAc substrate), as should be the case for the ER enzyme (Bischoff & Kornfeld, 1983 . The preparation appeared to be free of contaminating a-mannosidases sensitive to these inhibitors.
ER a-mannosidase activity was assayed with 4 mmpNPMan as substrate in 50 mM-potassium phosphate buffer, pH 6.5, and 10 uM-swainsonine (to inhibit any contaminating Golgi mannosidase II activity) in a total volume of 100 41. The assay mixture was incubated at 37°C for 60 min. The reaction was stopped by the addition of 0.2 M-Na2CO3 (1 ml). Release of pnitrophenol was determined by measuring the absorbance at 405 nm. ER a-mannosidase activity was also measured with [3H]Man9GlcNAc (5000 c.p.m.) as substrate.
Incubation time was for 3 h and mannose release was measured as described for the Golgi a-mannosidase I assay. However, in this case 10 /tM-l-deoxymannojirimycin was included in the assay mixture as an inhibitor of any contaminating mannosidases because swainsonine inhibits ER a-mannosidase at subsaturating substrate concentrations (Bischoff & Kornfeld, 1983) , and with the oligosaccharide as substrate it is not possible to saturate the enzyme. In addition, the main potential interfering enzyme is Golgi mannosidase I, which is insensitive to swainsonine but sensitive to 1-deoxymannojirimycin (Bischoff & Kornfeld, 1984) .
Jack-bean a-mannosidase assay
The commercially available enzyme was diluted 50-fold with 200 mM-sodium acetate buffer, pH 4.2, containing 40 /iM-ZnCl2. Diluted enzyme (1 jug of protein) was incubated with 100 mM-acetate buffer, pH 4.2, containing 20 ,uM-ZnCl2 and 5 mM-pNPMan for 5 min at 37 'C. The reaction was stopped by the addition of 0.2 M-Na2CO3, and the absorbance at 405 nm was measured to determine the release ofp-nitrophenol. One unit of enzyme activity catalyses the formation of 1 ,umol of p-nitrophenol/min at 37 'C.
Other procedures
Columns (1 cm x 100 cm) of Bio-Gel P6 (200-400 mesh) were used for the separation of glycopeptides generated by Pronase digestion of labelled glycoproteins. Elution was with 0.1 M-pyridinium acetate; 0.5 ml fractions were collected.
Labelled oligosaccharides were separated on columns (1 cm x 150 cm) of Bio-Gel P4 (-400 mesh) with 0.02 0/0 NaN3 as eluent; 0.4 ml fractions were collected. Concn. of MMNT (AM) Fig. 1 . Effect of MMNT on x-mannosidases from jack bean, rat liver Golgi membranes and rat liver ER membranes The enzymes were assayed as described in the Experimental section and were preincubated with MMNT for 5 min before the addition of substrate to initiate the reaction. When the substrate was pNPMan, separate blanks for each MMNT concentration were prepared to correct for any absorbance by the triazene. 0, Jack-bean amannosidase; *, rat liver Golgi a-mannosidase I; *, rat liver ER a-mannosidase with pNPMan substrate; Oi, ER Digestions with endoglucosaminidase H, Pronase and a-mannosidase were performed as previously described (Datema & Schwarz, 1981) .
Infection of monolayers of chick-embryo cells with influenza virus was done as described previously (Datema & Schwarz, 1981) . The cells were maintained in Dulbecco's medium containing 10 mM-glucose. Quantification of virus infectivity by plaque assay was performed as described by Klenk et al. (1975) , and the determination of haemagglutination titre was done by the procedure of Davenport et al. (1960) . Neuraminidase activity was assayed by the method of Drzenick et al. (1966) .
RESULTS AND DISCUSSION Inhibition of some c-mannosidases by MMNT
The effectiveness of MMNT as an inhibitor of amannosidase activity was tested with a commercially available jack-bean ac-mannosidase preparation and purified rat liver Golgi membranes containing a.-mannosidase I activity. In addition, purified rat liver ER membranes were used as a source of ER a-mannosidase activity. Incubation of MMNT with both jack-bean amannosidase and rat liver Golgi a-mannosidase I resulted in a concentration-dependent decrease in mannosidase activity towards their respective substrates (Fig. 1) . In both cases high concentrations of MMNT were required for inhibition. The MMNT concentrations giving 50 % Vol. 255 inhibition of activity were determined by extrapolation to be 0.18 mm and 0.32 mm for the Golgi and jack-bean enzymes respectively. These values are high when compared with 1-deoxymannojirimycin, which inhibits Golgi a-mannosidase I with a K, of 2 ,uM (Bischoff & Kornfeld, 1984) . However, since MMNT is a suicide substrate, one molecule will be required to inactivate each molecule of enzyme. Also, alkylaryltriazenes are known to be labile in solution at pH values below 7 and at elevated temperatures (Sinnott & Smith, 1978) , and this may be partly responsible for the relatively high concentrations of MMNT needed to inactivate the jackbean and rat liver Golgi a-mannosidases.
Incubation of MMNT with a partially purified ER amannosidase preparation did not inhibit enzyme activity towards pNPMan or [3H]MangGlcNAc (Fig. 1) . It was noted by Bischoff & Kornfeld (1983) (Fig. 2) . The inclusion of 0.5 mM-MMNT in the incubation mixture resulted in a significant decrease in mannose release over the total incubation period (Fig. 2) examined by gel filtration on Bio-Gel P4 (Fig. 3) . In the absence of inhibitor Man6GlcNAc and Man5GlcNAc are the only products of hydrolysis (Fig. 3a) . Increasing the MMNT concentration leads to a decrease in the amount of trimming taking place and to an increase in the size of the oligosaccharides present (Figs. 3b-3e ). In all incubations containing MMNT (Figs. 3b-3e) Man,GlcNAc is still present whereas it is absent from the control incubation (Fig. 3a) . (Fig. 4) . Analysis of the untreated sample showed that the viral glycoproteins are predominantly glycosylated with complex-type oligosaccharides (Fig. 4a) . Complextype glycopeptides, which were eluted between the void volume and the Glc3Man9GlcNAc marker, constituted 54% of the eluted radioactive label. A series of highmannose-type oligosaccharides with the elution characteristics of Man,GlcNAc, Man8GlcNAc, Man7GlcNAc and Man6GlcNAc were eluted after the marker (Fig. 4a) and constituted 46% of the eluted radioactive label. In contrast, in the treated sample the radioactive label associated with the complex-type glycopeptides was 25% and that associated with the high-mannose-type oligosaccharides was 75 %, indicating that the formation of complex-type oligosaccharides had been inhibited by treatment with MMNT. Analysis of the treated sample showed that the viral glycoproteins are glycosylated predominantly with highmannose-type oligosaccharides with the elution characteristics of Man8GlcNAc and Man7GlcNAc (Fig. 4b) Fraction no. Man7(GlcNAc)2 on the viral glycoproteins could be due to incomplete inhibition of the cellular a-mannosidase I activity. In order to examine this possibility, the activities of the cellular a-mannosidase activities towards Man9GlcNAc at pH 6.8 and pNPMan at pH 4.2 in Triton X-100 lysates prepared from infected cells treated with up to 2 mM-MMNT were assayed (Fig. 5) . Both mannosidase activities were inhibited to a maximum of about 60% after treatment of the cells with 1-2 mm-MMNT (Fig. 5) , confirming the suspicion that there was incomplete inhibition of ct-mannosidase I activity. These findings contrast with those obtained in a study with rat liver hepatocytes (Docherty et al., 1986) , in which an unspecified a-mannosidase activity was decreased to a residual level of 20 % with 1 mM-MMNT. In human skin fibroblasts treated with 1 mM-f6-galactopyranosylmethyl- Fig. 5 . Inhibition of a-mannosidase activities in influenza-virusinfected chick-embryo cells Virus-infected chick-embryo cells were treated with various concentrations of MMNT for 4 h. The medium was removed, and the cell monolayers were washed three times with 170 mM-NaCl/10 mM-sodium phosphate buffer, pH 7.6. The cells were lysed by incubation with 0.25 % Triton X-100 (200 u1) for 30 min on ice. The lysates were used immediately for the assay of a-mannosidase I (-) and acid a-mannosidase (0) as described for the rat liver and jack-bean enzymes with the exception that incubation times were 2 h and 30 min respectively. The enzyme activities were corrected for differences in protein concentration. Each point is the average for three separate experiments.
lower concentrations of triazene within the chick-embryo cell and thus a lower degree of inhibition than would have been expected from the results with hepatocytes and human skin fibroblasts. It is also possible that the residual neutral and acidic a-mannosidase activities are due respectively to cellular ER a.-mannosidase and Golgi mannosidase II, which can have activity towards pNPMan at pH 4.0 (Tulsiani et al., 1982a Datema et al., 1987) . As a consequence of these studies an essential role for glucose trimming in the establishment of a functional conformation for some viral glycoproteins has been found (Datema et 1985; Repp et al., 1985; McDowell et al., 1987) . In contrast, inhibition of mannose trimming has little effect with the exception of Sindbis virus, which buds from intracellular membranes in BHK cells treated with the mannosidase I inhibitor 1-deoxymannojirimycin (McDowell et al., 1987) . Trimming inhibitors have no effect on the formation of influenza A viruses (Romero et al., 1983; Pan et al., 1983; Datema et al., 1984; Elbein et al., 1984) except for the fowl-plague virus strain, the haemagglutinin of which is metabolically unstable when equipped with oligosaccharides of the composition Glc1Man,(GlcNAc)2 in the presence of bromoconduritol . The biological properties of influenza virus formed in the presence of MMNT were examined to see whether the changes in the oligosaccharide composition of the two viral membrane glycoproteins, the haemagglutinin and the neuraminidase, had altered their respective activities (Table 1) . Treatment of influenza-virus-A/ FPV/Rostock/34-infected chick-embryo cells with up to 1 mM-MMNT did not adversely affect either the haemagglutinin or the neuraminidase activities of the virus formed in the presence of the drug (Table 1) . However, 2 mM-MMNT was inhibitory in each case (Table 1 ). The infectivity of the virus was not affected by low concentrations (0.1-0.2 mM) of MMNT, but at higher concentrations (0.5-2.0 mM) there was a significant decrease in the virus titre as determined by plaque assay (Table 1) . Since MMNT did not affect protein synthesis in-influenza-virus-infected chickembryo cells except at a concentration of 2 mm (results not shown), it would appear that the synthesis of the influenza-virus haemagglutinin and neuraminidase are not affected by MMNT treatment, whereas the 1988 production of infectious virus particles seems to be sensitive. This contrasts with the effects of the mannosidase I inhibitor 1-deoxymannojirimycin, which has no effect on the formation of influenza virus (Elbein et al., 1984; . It is possible that influenzavirus haemagglutinin and neuraminidase glycosylated with predominantly high-mannose-type oligosaccharides of the composition Man7(GlcNAc)2 and Man8(GlcNAc)2 are not incorporated efficiently into influenza-virus particles. The infectivity of influenza viruses is known to be related to the cleavability of their haemagglutinins (Webster & Rott, 1987) . Thus in chick-embryo cells the haemagglutinin of fowl-plague virus is cleaved and the virus can form plaques, whereas that of influenza virus PR8 is not cleaved and plaques can only be formed if the virus is pretreated with trypsin (Klenk et al., 1975) . Thus there may be the possibility that MMNT treatment could have impaired the proteolytic cleavage of the fowlplague-virus haemagglutinin, producing virus particles containing an uncleaved haemagglutinin. Such virus particles would not form plaques in the plaque assay, giving rise to diminished virus titres. However, pretreatment of virus formed in the presence of MMNT with trypsin (10 ltg/ml) for 20 min at 37°C did not increase the infectivity of the virus (results not shown). In addition, the infectivity of influenza virus PR8 was affected by MMNT treatment in a similar fashion to that of fowl-plague virus (results not shown). This would not have been the case if there was an effect on the cleavability of the haemagglutinin, since influenza virus PR8 needs to be pretreated with trypsin before determination of the virus infectivity by plaque assay in chick-embryo cells (Klenk et al., 1975) . Therefore an effect on the cleavage of the haemagglutinin as a cause of the decrease in infectivity of influenza virus synthesized in the presence of 1 mM-MMNT can be ruled out. Thus it would appear that the two viral glycoproteins are not being efficiently incorporated into virus particles in MMNT-treated cells.
The results presented indicate that MMNT is an inhibitor of oligosaccharide trimming catalysed by Golgi oc-mannosidase I and is a useful addition to the oligosaccharide-processing inhibitors already available. Since glycosylmethyl-p-nitrophenyltriazenes are activesite-directed irreversible inhibitors of glycosidases, they can be used to study turnover of these enzymes, as shown by Van Diggelen et al. (1980) . Indeed the use of MMNT in a study of the degradation and biosynthesis of oligosaccharide chains on a.-acid glycoprotein in perfused liver and in cultured hepatocytes (Docherty et al., 1986) indicates the feasibility of such an approach.
During the preparation of the manuscript a paper by Docherty & Aronson (1987) dealing with the effects of MMNT on rat liver a-mannosidases was published. Their findings were largely similar to those reported here, and in addition it was reported that Golgi mannosidase II is virtually insensitive to MMNT treatment. It was also reported that a soluble cz-mannosidase, deemed to be the ER enzyme, was inhibited by 90 % with 1 mM-MMNT. In contrast, we have found a more purified preparation of ER a-mannosidase to be less sensitive to MMNT. The ER a-mannosidase and soluble amannosidase of rat liver have essentially the same properties and have been shown to be immunologically related (Bischoff & Kornfeld, 1986) . The contradiction between our findings and those of Docherty & Aronson (1987) may be due to the fact that the free cytosolic enzyme is more sensitive to MMNT than is the membrane-bound enzyme. This could be brought about by the two enzymes adopting different conformations. The cytosolic enzyme may be less constrained than the membrane-bound enzyme, the conformation of which may be subject to interactions from the other protein components of the ER membrane.
